CTC - Immune Based Biomarkers (Kidney & Bladder Cancer) - Clinical Trial
What is the Purpose of this Study?
If you choose to join this study, there will be four different timepoints.
At these timepoints, we will:
- Collect blood, urine and stool samples
- Review your chart to find out how your body is reacting to the immunotherapy and how your cancer is responding to the immunotherapy.
What is the Condition Being Studied?
Advanced Kidney and Bladder Cancer
Who Can Participate in the Study?
Adult patients with renal or bladder cancer who are planning to start an immunotherapy.
Age Group
Adults
What is Involved?
We are doing this study learn more about circulating immune cells and circulating tumor cells (CTCs) in patients with metastatic renal cell carcinoma or metastatic urothelial carcinoma.
We are also looking at the bacteria in your gut and urinary tract to learn about how these bacteria affect how your cancer responds to immunotherapy.
Study Details
Full Title
Exploring relevant immune-based biomarkers and circulating tumor cells during treatment with immune checkpoint inhibitors in genitourinary malignancies
Principal Investigator
Shahla Bari
Protocol Number
IRB:
PRO00076768
NCT:
NCT02978118
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-681-1030